4.1 Letter

Tildrakizumab for treatment of refractory pyoderma gangrenosum of the penis and polymyalgia rheumatica: Killing two birds with one stone

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Treatment of polymyalgia rheumatica

Santos Castaneda et al.

BIOCHEMICAL PHARMACOLOGY (2019)

Review Immunology

Pyoderma gangrenosum: a review of pathogenesis and treatment

Christine Ahn et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)

Review Pharmacology & Pharmacy

Drug therapies for polymyalgia rheumatica: a pharmacotherapeutic update

Miguel A. Gonzalez-Gay et al.

EXPERT OPINION ON PHARMACOTHERAPY (2018)

Letter Dermatology

Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab

Ari M. Goldminz et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)

Article Dermatology

Interleukin 23 Expression in Pyoderma Gangrenosum and Targeted Therapy With Ustekinumab

Emmanuella Guenova et al.

ARCHIVES OF DERMATOLOGY (2011)